3 active not recruiting, 2 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Active not recruiting 3, Terminated 2 |
Follow Thyroid Gland Carcinoma: new trials by email Literature Review of Thyroid Gland Carcinoma trials Research Report on Thyroid Gland Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer Gallium Ga 68-labeled PSMA-11, Magnetic Resonance Imaging, Positron Emission Tomography (PET) - Thyroid Gland Carcinoma | Phase 2 | Terminated | University of California, San Francisco | 12 | 2018-03-19 | 2021-06-29 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord Computed Tomography, Quality-of-Life Assessment, Questionnaire Administration - Malignant Digestive System Neoplasm, Metastatic Head and Neck Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 60 | 2016-08-29 | 2026-10-07 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Adavosertib, Afatinib, Afatinib Dimaleate - Advanced Lymphoma, Advanced Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 6452 | 2015-08-17 | 2026-11-12 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy Doxepin Hydrochloride, Placebo, Quality-of-Life Assessment - Esophageal Carcinoma, Hypopharyngeal Carcinoma | Phase 2 | Terminated | Mayo Clinic | 5 | 2014-04-14 | 2019-10-01 |
Thyroid Neoplasms (5) · Carcinoma, Renal Cell (2) · Esophageal Neoplasms (2) · Lymphoma (2) · Melanoma (2) · Sarcoma (2) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenocarcinoma, Mucinous (1) · Adrenocortical Carcinoma (1) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Acinar Cell (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Basal Cell (1) · Carcinoma, Endometrioid (1)
Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Head and Neck Neoplasms (5) · Neoplasms (5) · Neoplasms by Site (5) · Thyroid Diseases (5) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Adenocarcinoma (3) · Carcinoma (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3)
Magnetic Resonance Spectroscopy (3) · Nivolumab (2) · Specimen Handling (2) · X-Rays (2) · 2-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide (1) · 2C4 antibody (1) · AZD4547 (1) · Ado-Trastuzumab Emtansine (1) · Afatinib (1) · Biopsy (1) · CT-P6 (1) · CTLA-4 Antigen (1) · Crizotinib (1) · Dasatinib (1) · Disulfides (1)
National Cancer Institute (NCI) (2) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · University of California, San Francisco (1)
United States (5) · Guam (2) · Puerto Rico (1)
Jing Li (1) · Keith T Flaherty (1) · Robert Flavell, MD, PhD (1) · Sandip P Patel (1) · Terence Sio (1)
PMID 26586415, PMID 31969335, PMID 32463741, PMID 33048619, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34716198, PMID 35133871, PMID 35138919, PMID 36351402, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38243705, PMID 38358334, PMID 38591867, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39666929, PMID 39693587, PMID 39856213, PMID 39913886, PMID 40402690, PMID 40588371, PMID 40865033, PMID 41066729, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
P30CA015083 (1), P30CA016672 (1), U10CA180820 (1), U10CA180888 (1), U24CA196172 (1)